Hydra Biosciences Inc., a Cambridge biotech company, confirmed reports it raised $34 million in its third round of venture capital, led by Advanced Technology Ventures. To date, the company has raised $63 million in funding from several investors, including Biogen Idec New Ventures, Lilly Ventures, and Polaris Venture Partners.
